Search

Search Constraints

You searched for: Author/Creator Robledo, Mercedes

Search Results

1. Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene. (12th March 2015)

2. Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients. (December 2018)

3. Gain-of-function mutations in DNMT3A in patients with paraganglioma. (December 2018)

5. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients. Issue 10 (12th August 2015)

6. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases. Issue 5 (6th April 2012)

7. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Issue 8 (August 2020)

8. Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas. Issue 4 (1st July 2020)

9. Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy. (23rd November 2018)

10. Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma. Issue 1 (5th June 2021)